Michael R Mayer

US Patent:

7387563, Jun 17, 2008

Filed:

Jul 21, 2005

Appl. No.:

11/187139

Inventors:

Markus Allemann - Grayslake IL, US
Edward G. Ennis - Niles IL, US
Vera Maras - Schaumburg IL, US
Jose Nieto - Chicago IL, US
Bradley J. Albrecht - Cahokia IL, US
Simon C. Dirnberger - Tulsa OK, US
Alan S. Kremzar - Cedar Rapids IA, US
Michael C. Mayer - Smithshire IL, US
Alexandria L. Merritt - Hannibal MO, US
Amanda B. Raffurty - Lee's Summit MO, US

Assignee:

Robert Bosch GmbH - Stuttgart

International Classification:

B24B 23/02

US Classification:

451342, 451508

Abstract:

A mandrel and accessory and related combination for use with a rotary tool are disclosed. For instance, the mandrel and accessory combination includes a mandrel assembly and an accessory. The mandrel assembly includes (i) a shaft component defining an axis and having a first portion configured to be received in a chuck of a power tool, and a second portion having a first shaft tooth and a second shaft tooth each extending in a perpendicular manner with respect to the axis, and (ii) a collar component defining a passage through which the shaft component extends, the collar component having a first collar tooth and a second collar tooth. The accessory includes an outer wall structure defining a circular outer periphery; and an inner wall structure defining a coupling opening. The accessory is configured to be releasably coupled to the mandrel assembly.

US Patent:

20180311217, Nov 1, 2018

Filed:

Dec 1, 2017

Appl. No.:

15/828680

Inventors:

- Deerfield IL, US
- Tokyo, JP
Himanshu Naik - Evanston IL, US
Michael Mayer - Antioch IL, US
Kanji Komatsu - Tokyo, JP

Assignee:

Takeda Pharmaceuticals U.S.A., Inc. - Deerfield IL
Teijin Pharma Limied - Tokyo

International Classification:

A61K 31/426
A61K 9/50
A61K 31/165
A61K 9/16

Abstract:

Methods and pharmaceutical compositions for reducing number of gout flares experienced by a patient are disclosed. The methods can comprise administering to a patient with hyperuricemia an effective amount of a xanthine oxidase inhibitor in a modified release dosage form once daily or in an immediate release dosage form two or more times daily to prevent at least one gout flare or reduce the number of gout flares experienced by the patient.

US Patent:

20140357683, Dec 4, 2014

Filed:

May 30, 2014

Appl. No.:

14/292010

Inventors:

- Deerfield IL, US
- Tokyo, JP
Himanshu Naik - Evanston IL, US
Michael Mayer - Antioch IL, US
Kanji Komatsu - Tokyo, JP

International Classification:

A61K 31/426
A61K 31/165

US Classification:

514365

Abstract:

Methods and pharmaceutical compositions for reducing number of gout flares experienced by a patient are disclosed. The methods can comprise administering to a patient with hyperuricemia an effective amount of a xanthine oxidase inhibitor in a modified release dosage form once daily or in an immediate release dosage form two or more times daily to prevent at least one gout flare or reduce the number of gout flares experienced by the patient.